Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Stimcell EnergeticsSTME 26 3-1 Month Momentum % is 15.51% as of Jul. 24, 2026. GuruFocus rates STME with a GF Score™ of 26/100. The stock has 4 warning signs investors should review. Among 847 Medical Devices & Instruments companies, Stimcell Energetics ranks better than 89.26% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-07-24), Stimcell Energetics's 3-1 Month Momentum % is 15.51%.
The industry rank for Stimcell Energetics's 3-1 Month Momentum % or its related term are showing as below:
STME's 3-1 Month Momentum % is ranked better than 89.26% of 847
companies
in the Medical Devices & Instruments industry
Industry Median: -9.34
vs STME: 15.51
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Stimcell Energetics 3-1 Month Momentum % Related Terms
STME vs NVNO, TRIB, AIDX: 3-1 Month Momentum % Comparison
For the Medical Devices subindustry, Stimcell Energetics's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Stimcell Energetics 3-1 Month Momentum % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Stimcell Energetics's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Stimcell Energetics's 3-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Stimcell Energetics (STME) has a 3-1 Month Momentum % of 15.51% as of Jul. 24, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Stimcell Energetics and its competitors. According to the industry distribution chart, Stimcell Energetics ranks #91 out of 847 companies in the Medical Devices & Instruments industry, placing it in the top 10.7%.
Is Stimcell Energetics' 3-1 Month Momentum % too high?
Stimcell Energetics' current 3-1 Month Momentum % is 15.51%. Based on the distribution chart, Stimcell Energetics ranks #91 out of 847 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Stimcell Energetics has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Stimcell Energetics' 3-1 Month Momentum % compare to NVNO and TRIB?
According to the Medical Devices & Instruments industry distribution chart, Stimcell Energetics ranks #91 out of 847 companies for 3-1 Month Momentum %. This places Stimcell Energetics in the top 11% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Devices & Instruments company?
A good 3-1 Month Momentum % depends on the Medical Devices & Instruments industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Stimcell Energetics and its competitors. Stimcell Energetics's current 3-1 Month Momentum % is 15.51%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stimcell Energetics stock overvalued right now?
Stimcell Energetics (STME) has a current 3-1 Month Momentum % of 15.51%. The current 3-1 Month Momentum % is 15.51%. Stimcell Energetics' overall GF Score™ is 26/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Stimcell Energetics (STME), the current 3-1 Month Momentum % is 15.51% as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Stimcell Energetics Inc is a biotech company focused on the discovery, development, and commercialization of therapeutic and non-therapeutic products that enhance cellular function, promote general wellness, and alleviate health complications, including, but not limited to: aging, diabetes, high blood pressure, neuropathy, and kidney function. The company's main focus is on continued research and development of its eBalance Technology and its eBalance Home System.
26GF Score
Get the complete analysis for STME
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STME has been successfully added to your 
